Neuromyelitis optica spectrum disorder (NMOSD) is a rare relapsing neuroinflammatory
autoimmune astrocytopathy, with a predilection for the optic nerves and spinal cord. Most …

Introduction The coronavirus disease 2019 (COVID‐19) pandemic has hampered the
progress of neurological healthcare services for patients across Africa. Before the pandemic …

The standard of care for patients with neuromyelitis optica (NMO) has become highly
unequal globally. Sufficient data have been published to demonstrate that NMO is a …

Background: Neuromyelitis optic spectrum disorder (NMOSD) is a rare demyelinating,
autoimmune disease and the burden in United States is not well characterized. Objective …

Background Optic neuritis is a relatively common disease with an estimated lifetime risk of
0.6 per 1000; the estimated prevalence is 1–5 per 100 000/year. It occurs because of …

Background: Previous studies in the United States established multiple sclerosis (MS) as the
most common cause of optic neuritis (ON). ON can be associated with other systemic …

Key clinical message Neuromyelitis optica spectrum disorder is an autoimmune disease,
rarely presents with antiphospholipid syndrome. Diagnosis and management of NMOSD are …

Background Neuromyelitis optica spectrum disorders (NMOSD) may have a great impact on
patients' marriage, and marital status may also affect patients' compliance and prognosis …

Mechanical thrombectomy (MT) has revolutionized the management of proximal large
vessel occlusions (LVOs) in patients with acute ischemic stroke (AIS), improving long-term …

This case series highlights the diverse presentations of seropositive neuromyelitis optica
spectrum disorder, including the absence of optic neuritis despite anti‐aquaporin 4 antibody …